Showing results (241-250 of 255) with videos related to

Sort By:
Pageof 26
Genes|May 15, 2019
Outcome Definition Influences the Relationship Between Genetic Polymorphisms of ERCC1, ERCC2, SLC22A2 and Cisplatin Nephrotoxicity in Adult Testicular Cancer PatientsZulfan Zazuli, Leila S Otten, Britt I Drögemöller, et al.
Clinical Microbiology Reviews|June 9, 2021
Clinical Laboratory Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a Safer FutureNancy E Cornish, Nancy L Anderson, Diego G Arambula, et al.
The Lancet. Infectious Diseases|July 24, 2015
Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trialDavid A Margolis, Cynthia C Brinson, Graham H R Smith, et al.
Frontiers in Psychiatry|January 24, 2022
Interactions Between Opioids and Dextroamphetamine on Locomotor Activity: Influence of an Opioid's Relative Efficacy at the Mu ReceptorMark A Smith, Shannon L Ballard, Clarise F Ballesteros, et al.
JAMA Oncology|April 28, 2017
Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular CancerBritt I Drögemöller, Jose G Monzon, Amit P Bhavsar, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 2, 2022
Patient-specific genetic factors predict treatment failure in sofosbuvir-treated patients with chronic hepatitis CCatrina M Loucks, Jennifer J Lin, Jessica N Trueman, et al.
Nature Genetics|July 18, 2018
Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosisKaarina Kowalec, Galen E B Wright, Britt I Drögemöller, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 12, 2022
A pharmacogenomic investigation of the cardiac safety profile of ondansetron in children and pregnant womenBritt I Drögemöller, Galen E B Wright, Jessica Trueman, et al.
Frontiers in Pharmacology|November 1, 2021
The Extent and Impact of Variation in ADME Genes in Sub-Saharan African PopulationsJorge E B da Rocha, Houcemeddine Othman, Gerrit Botha, et al.
Lancet (London, England)|July 29, 2017
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trialDavid A Margolis, Juan Gonzalez-Garcia, Hans-Jürgen Stellbrink, et al.
Pageof 26